Complete Story
04/11/2017
NCCN has published updates to the NCCN Templates® for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) to reflect the currently published NCCN Guidelines.
- Regimen information for the following templates has been updated to reflect a change in dosing for bendamustine in relapsed/refractory CLL/SLL (70 mg/m2 for patients of all ages):
- CLL21 – BendamustineCLL22 – Bendamustine + Rituximab
For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Drugs & Biologics Compendium (NCCN Compendium®), the NCCN Biomarkers Compendium®, the NCCN Templates®, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!